rewirebio.iobenchmarks
Dataset subset

TCGA stomach adenocarcinomas with INSR at least 10 TPM (166)

TCGA stomach tumours with INSR expression of at least 10 TPM.

Evaluation results

5 evaluations · 5 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Method: Cohort mean isoform splitProtocol: INSR isoform split in TCGA stomach tumours, mean absolute error
Dataset subset: TCGA stomach adenocarcinomas with INSR at least 10 TPM (166)
12.2% MAE (mean absolute error of INSR isoform percentage, 166 TCGA stomach tumours)
percent · lower

Uncertainty: Not reported by the source: The caption says intervals are given, but none is printed for MAE.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cohort mean, INSR isoform split in 166 stomach tumours, MAE

ladon-20261115-protocol-insr-stomach-mae

Aggregation: Not reported

Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 11 (page 24) readout 'MAE, points', 'cohort mean'
Method: Cohort-trained isoform ridge baseline (Ladon report)Protocol: INSR isoform split in TCGA stomach tumours, mean absolute error
Dataset subset: TCGA stomach adenocarcinomas with INSR at least 10 TPM (166)
6.6% MAE (mean absolute error of INSR isoform percentage, 166 TCGA stomach tumours)
percent · lower

Uncertainty: Not reported by the source: The caption says intervals are given, but none is printed for MAE.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cohort-trained baseline, INSR isoform split in 166 stomach tumours, MAE

ladon-20261115-protocol-insr-stomach-mae

Aggregation: Not reported

Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 11 (page 24) readout 'MAE, points', 'cohort-trained baseline'
Method: Cohort-trained isoform ridge baseline (Ladon report)Protocol: INSR isoform split in TCGA stomach tumours, Pearson r
Dataset subset: TCGA stomach adenocarcinomas with INSR at least 10 TPM (166)
0.84 Pearson (Pearson r between predicted and measured INSR isoform percentages, 166 TCGA stomach tumours with INSR at least 10 TPM)
unitless · higher

Uncertainty: 95% CI 0.79 to 0.88. percentile bootstrap with predictions held fixed, tumours resampled

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cohort-trained baseline, INSR isoform split in 166 stomach tumours, Pearson r

ladon-20261115-protocol-insr-stomach-pearson

Aggregation: Not reported

Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 11 (page 24) readout 'r with measured', 'cohort-trained baseline'
Configuration: Ladon, pretrained encoder, isoform percentages imputed from gene-level countsProtocol: INSR isoform split in TCGA stomach tumours, mean absolute error
Dataset subset: TCGA stomach adenocarcinomas with INSR at least 10 TPM (166)
4.9% MAE (mean absolute error of INSR isoform percentage, 166 TCGA stomach tumours)
percent · lower

Uncertainty: Not reported by the source: The caption says intervals are given, but none is printed for MAE.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Ladon, INSR isoform split in 166 stomach tumours, MAE

ladon-20261115-protocol-insr-stomach-mae

Aggregation: Not reported

Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 11 (page 24) readout 'MAE, points', 'Ladon'
Configuration: Ladon, pretrained encoder, isoform percentages imputed from gene-level countsProtocol: INSR isoform split in TCGA stomach tumours, Pearson r
Dataset subset: TCGA stomach adenocarcinomas with INSR at least 10 TPM (166)
0.93 Pearson (Pearson r between predicted and measured INSR isoform percentages, 166 TCGA stomach tumours with INSR at least 10 TPM)
unitless · higher

Uncertainty: 95% CI 0.91 to 0.95. percentile bootstrap with predictions held fixed, tumours resampled

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Ladon, INSR isoform split in 166 stomach tumours, Pearson r

ladon-20261115-protocol-insr-stomach-pearson

Aggregation: Not reported

Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 11 (page 24) readout 'r with measured', 'Ladon'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Subset and evaluation context

This record describes a particular subset or cohort used in an evaluation. Its results do not describe the full dataset.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

10 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Eligible count
166
Context-only references
Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF)

Original source ↗

Page 23 prose; page 28, Methods 'Tumor cohorts'

Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Retrieved: 2026-11-15T20:29:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.eligible_count

Source artifact SHA-256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c

Hash scope: Hash scope not separately documented; inspect source record

Source dataset
ladon-20261115-data-tcga
Context-only references
Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF)

Original source ↗

Page 23 prose; page 28, Methods 'Tumor cohorts'

Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Retrieved: 2026-11-15T20:29:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_dataset

Source artifact SHA-256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c

Hash scope: Hash scope not separately documented; inspect source record

Source location
Page 23 prose; page 28, Methods 'Tumor cohorts'
Context-only references
Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF)

Original source ↗

Page 23 prose; page 28, Methods 'Tumor cohorts'

Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Retrieved: 2026-11-15T20:29:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c

Hash scope: Hash scope not separately documented; inspect source record

Split
Evaluation only
Context-only references
Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF)

Original source ↗

Page 23 prose; page 28, Methods 'Tumor cohorts'

Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Retrieved: 2026-11-15T20:29:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.split

Source artifact SHA-256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c

Hash scope: Hash scope not separately documented; inspect source record

Subset scope
166 stomach tumours, INSR at least 10 TPM
Context-only references
Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF)

Original source ↗

Page 23 prose; page 28, Methods 'Tumor cohorts'

Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Retrieved: 2026-11-15T20:29:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.subset_scope

Source artifact SHA-256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c

Hash scope: Hash scope not separately documented; inspect source record

Version
As described in the Ladon technical report
Context-only references
Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF)

Original source ↗

Page 23 prose; page 28, Methods 'Tumor cohorts'

Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Retrieved: 2026-11-15T20:29:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c

Hash scope: Hash scope not separately documented; inspect source record

Description
TCGA stomach tumours with INSR expression of at least 10 TPM.
Context-only references
Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF)

Original source ↗

Page 23 prose; page 28, Methods 'Tumor cohorts'

Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Retrieved: 2026-11-15T20:29:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c

Hash scope: Hash scope not separately documented; inspect source record

Relationship: used in
ladon-20261115-protocol-insr-stomach-mae
Context-only references
Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF)

Original source ↗

Page 23 prose; page 28, Methods 'Tumor cohorts'

Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Retrieved: 2026-11-15T20:29:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: links:used_in:ladon-20261115-protocol-insr-stomach-mae

Source artifact SHA-256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c

Hash scope: Hash scope not separately documented; inspect source record

Relationship: used in
ladon-20261115-protocol-insr-stomach-pearson
Context-only references
Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF)

Original source ↗

Page 23 prose; page 28, Methods 'Tumor cohorts'

Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Retrieved: 2026-11-15T20:29:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: links:used_in:ladon-20261115-protocol-insr-stomach-pearson

Source artifact SHA-256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c

Hash scope: Hash scope not separately documented; inspect source record

Name
TCGA stomach adenocarcinomas with INSR at least 10 TPM (166)
Context-only references
Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF)

Original source ↗

Page 23 prose; page 28, Methods 'Tumor cohorts'

Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Retrieved: 2026-11-15T20:29:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c

Hash scope: Hash scope not separately documented; inspect source record

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ladon-20261115-data-tcga-stomach-insr.

Source locator: Page 23 prose; page 28, Methods 'Tumor cohorts'

Related records

Suggest a correction